Cetera Investment Advisers’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Cetera Investment Advisers's LMAT Position: Q2 2026 in Review
Cetera Investment Advisers reduced its LeMaitre Vascular (LMAT) stake by 6% in Q2 2026, selling an estimated $192K and leaving 29,557 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2092.
Cetera Investment Advisers first reported a position in LMAT in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.43M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Cetera Investment Advisers held 29,557 shares of LeMaitre Vascular worth $2.84M as of Q2 2026.
- Cetera Investment Advisers sold 1,872 LeMaitre Vascular shares in Q2 2026, an estimated $192K.
- LeMaitre Vascular made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2092 holding.
- Cetera Investment Advisers first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 9 quarters since.
- Cetera Investment Advisers's LeMaitre Vascular position peaked at $3.43M in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.